News|Articles|October 28, 2025
Executive Summary: Charge Detection Mass Spectrometry (CDMS): From Complexity to Clarity – A New Era in Biomolecular Analysis
Author(s)Waters Corporation
Key Takeaways
CDMS is reshaping the characterization of complex biotherapeutics by enabling precise analysis of large, heterogeneous biomolecular complexes and gene therapy vectors. This article explores how CDMS enhances resolution in quality assessments across biotherapeutic development and structural biology research—surpassing the capabilities of conventional analytical techniques.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Ask the Expert: Audits, Inspections, and CDMOs
2
How Programmable Biology Could Reshape Biologic Drug Development
3
Launch in Lockstep: Biopharma Readiness for the CNPV’s Accelerated Clock
4
How Sapient’s Next-Gen Proteomics Platform Helps Quantify Proteins at Scale
5
